Golden Throat (6896 HK): China’s Leading Lozenge Maker at 10x P/E and a 10% Dividend Yield

443 Views01 Sep 2025 10:29

Golden Throat (6896 HK — US$343 million) is an iconic Chinese brand of throat lozenges, used to deal with sore or dry throats. The core product is similar to Strepsils, Halls, or Ricola...

What is covered in the Full Insight:

Introduction to Golden Throat
Historical Background and Key Developments
Market Position and Financial Performance
Challenges and Recent Performance
Outlook and Investment Considerations

Asian Century Stocks

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 18-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream